Citrine Medicine To Present at the 2021 WuXi Healthcare Forum and Participate in Two Additional Upcoming Healthcare Conferences
CAMBRIDGE, Mass. and SHANGHAI, March 16, 2021 /PRNewswire/ -- Citrine Medicine, a China-based rare disease therapeutics company, today announced that it will participate in three industry conferences in March, including a presentation at the 2021 WuXi Healthcare Forum, which will be held from March 15-18, 2021.
Conference details are as follows:
About Citrine Medicine
Citrine Medicine is dedicated to improving the lives of patients with rare and intractable diseases by making diagnosis and essential treatments available and accessible to those who need them in China. Our mission is to build the first rare disease ecosystem in China and in doing so, enable people with rare diseases to live more normal lives. In addition to developing and marketing rare disease drugs, Citrine aims to establish a patient-centric platform which educates people on rare diseases, trains doctors on diagnosis and treatment, and helps doctors develop a full disease management protocol. Citrine's lead product candidate, Wakix® (pitolisant), is an investigational oral drug in development for the treatment of narcolepsy and obstructive sleep apnea in China. Citrine has initiated an Investigational New Drug (IND) submission for pitolisant in the treatment of narcolepsy and expects to complete the IND submission in the first quarter of 2021. Citrine also recently announced a strategic partnership that will allow the company exclusive rights to develop, register, and commercialize Alkindi®—the first clinically validated pediatric treatment for congenital adrenal hyperplasia—in the Greater China market. Citrine is headquartered in Shanghai and has other offices in Beijing, China and Cambridge, Mass.
For more information, visit www.citrinemed.com
Citrine Medicine Media Contacts:
View original content to download multimedia:http://www.prnewswire.com/news-releases/citrine-medicine-to-present-at-the-2021-wuxi-healthcare-forum-and-participate-in-two-additional-upcoming-healthcare-conferences-301248224.html
SOURCE Citrine Medicine